GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA).
Journal of neurology
View this publicationJournal of neurology
View this publicationCommunications biology
View this publicationAdvances in therapy
View this publicationJournal of fungi (Basel, Switzerland)
View this publicationResearch and practice in thrombosis and haemostasis
View this publicationCurrent biology : CB
View this publicationMolecular neurodegeneration
View this publicationNature
View this publicationGlia
View this publicationAging cell
View this publication